Publication | Closed Access
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
420
Citations
15
References
2016
Year
Hematological MalignancyLymphoid NeoplasiaTranslational MedicineMedicinePharmacologyClinical TrialsImmunologyMultiple MyelomaPharmacotherapyOncologyBromodomain Inhibitor Otx015Cancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1